tiprankstipranks
Botanix Pharmaceuticals Limited (AU:BOT)
ASX:BOT
Australian Market
BOT
Botanix Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see AU:BOT full AI Analyst Report?

Botanix Pharmaceuticals Limited (BOT) Ratios

171 Followers

Botanix Pharmaceuticals Limited Ratios

AU:BOT's free cash flow for Q4 2026 was AU$-1.70. For the 2026 fiscal year, AU:BOT's free cash flow was decreased by AU$ and operating cash flow was AU$-1.98. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 2.59 2.59 4.00 22.21 7.42
Quick Ratio
 1.58 1.58 2.87 21.89 5.75
Cash Ratio
 1.18 1.18 2.61 21.25 5.44
Solvency Ratio
 -1.62 -1.64 -1.76 -3.70 -4.80
Operating Cash Flow Ratio
 -2.09 -2.09 -3.15 -2.18 -6.41
Short-Term Operating Cash Flow Coverage
 -4.52 -4.52 -8.51 0.00 0.00
Net Current Asset Value
AU$ 37.82MAU$ 37.82MAU$ 51.79MAU$ 79.17MAU$ 12.09M
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.14 0.25 0.00 0.00
Debt-to-Equity Ratio
 0.23 0.23 0.40 0.00 0.00
Debt-to-Capital Ratio
 0.19 0.19 0.29 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.21 0.00 0.00
Financial Leverage Ratio
 1.67 1.67 1.59 1.03 1.08
Debt Service Coverage Ratio
 -3.98 -4.05 -5.52 -1.29K -109.65
Interest Coverage Ratio
 -24.43 -24.43 -15.05 -1.48K -156.55
Debt to Market Cap
 0.38 0.35 0.05 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 0.02 <0.01 <0.01
Net Debt to EBITDA
 0.32 0.32 0.40 5.20 0.81
Profitability Margins
Gross Profit Margin
-172.20%-172.20%34.85%-1016.72%-332.91%
EBIT Margin
-200.82%-200.82%-1432.23%-2546.73%-1392.57%
EBITDA Margin
-197.39%-200.82%-1393.13%-2534.66%-1380.50%
Operating Profit Margin
-200.82%-200.82%-1395.62%-2614.12%-1398.49%
Pretax Profit Margin
-202.15%-202.15%-1492.37%-2304.68%-1401.46%
Net Profit Margin
-202.15%-202.15%-1492.37%-2304.68%-1000.47%
Continuous Operations Profit Margin
-202.15%-202.15%-1492.37%-2304.68%-1000.47%
Net Income Per EBT
100.00%100.00%100.00%100.00%71.39%
EBT Per EBIT
100.66%100.66%106.93%88.16%100.21%
Return on Assets (ROA)
-65.83%-65.83%-66.92%-12.33%-36.86%
Return on Equity (ROE)
-118.74%-109.83%-106.27%-12.76%-39.88%
Return on Capital Employed (ROCE)
-92.42%-92.42%-77.56%-14.47%-55.75%
Return on Invested Capital (ROIC)
-77.62%-77.62%-70.96%-12.94%-39.80%
Return on Tangible Assets
-86.03%-86.03%-85.57%-16.72%-64.89%
Earnings Yield
-153.88%-169.61%-14.63%-2.93%-6.10%
Efficiency Ratios
Receivables Turnover
 5.20 5.20 2.03 0.74 1.87
Payables Turnover
 16.03 16.03 0.43 2.62 2.85
Inventory Turnover
 3.00 3.00 0.13 5.91 1.26
Fixed Asset Turnover
 42.26 42.26 4.18 8.38 14.00
Asset Turnover
 0.33 0.33 0.04 <0.01 0.04
Working Capital Turnover Ratio
 0.75 0.56 0.08 0.01 0.11
Cash Conversion Cycle
 169.27 169.27 2.04K 418.02 356.96
Days of Sales Outstanding
 70.24 70.24 179.89 495.53 195.12
Days of Inventory Outstanding
 121.80 121.80 2.72K 61.71 289.99
Days of Payables Outstanding
 22.77 22.77 858.35 139.22 128.15
Operating Cycle
 192.04 192.04 2.90K 557.24 485.11
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.03 -0.04 >-0.01 -0.01
Free Cash Flow Per Share
 -0.03 -0.03 -0.04 -0.02 -0.02
CapEx Per Share
 <0.01 <0.01 <0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 3.21 1.58
Dividend Paid and CapEx Coverage Ratio
 -16.15M -21.53M -274.36 -0.45 -1.71
Capital Expenditure Coverage Ratio
 -16.15M -21.53M -274.36 -0.45 -1.71
Operating Cash Flow Coverage Ratio
 -4.38 -4.38 -2.42 0.00 0.00
Operating Cash Flow to Sales Ratio
 -1.87 -1.87 -13.57 -13.50 -13.20
Free Cash Flow Yield
-170.63%-157.04%-13.36%-5.52%-12.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.59 -0.59 -6.84 -34.10 -16.39
Price-to-Sales (P/S) Ratio
 1.10 1.19 101.98 785.94 163.95
Price-to-Book (P/B) Ratio
 0.71 0.65 7.26 4.35 6.54
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.59 -0.64 -7.49 -18.10 -7.84
Price-to-Operating Cash Flow Ratio
 -0.70 -0.64 -7.51 -58.20 -12.42
Price-to-Earnings Growth (PEG) Ratio
 -0.02 0.02 -0.02 -2.07 0.40
Price-to-Fair Value
 0.71 0.65 7.26 4.35 6.54
Enterprise Value Multiple
 -0.23 -0.28 -6.92 -25.81 -11.06
Enterprise Value
 15.97M 19.24M 557.94M 393.68M 139.76M
EV to EBITDA
 -0.23 -0.28 -6.92 -25.81 -11.06
EV to Sales
 0.46 0.56 96.38 654.16 152.75
EV to Free Cash Flow
 -0.25 -0.30 -7.07 -15.07 -7.31
EV to Operating Cash Flow
 -0.25 -0.30 -7.10 -48.44 -11.58
Tangible Book Value Per Share
 0.02 0.02 0.03 0.05 0.01
Shareholders’ Equity Per Share
 0.03 0.03 0.04 0.07 0.02
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 <0.01 0.11 0.29
Revenue Per Share
 0.01 0.02 <0.01 <0.01 <0.01
Net Income Per Share
 -0.03 -0.03 -0.05 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 0.71
Interest Burden
 1.01 1.01 1.04 0.90 1.01
Research & Development to Revenue
 0.00 0.00 0.02 3.01 6.26
SG&A to Revenue
 0.29 0.29 14.28 11.05 3.32
Stock-Based Compensation to Revenue
 0.00 0.00 3.54 7.30 1.66
Income Quality
 0.93 0.93 0.91 0.59 1.32
Currency in AUD